On November 14, 2014, the listing ceremony of Taienkang’s new third board was held in Beijing National Small and Medium Enterprise Share Transfer System Co., Ltd., Mr. Zheng Hanjie, chairman of the board, rang the gong and delivered a speech at the listing ceremony. Taienkang has passed the review and approval with standardized governance and excellent business performance. The company’s stock has been listed and traded on the National Small and Medium Enterprise Share Transfer System under the supervision of the National Securities Regulatory Commission on October 8.

Chairman Mr. Zheng Hanjie said in his speech that as a professional marketer of pharmaceutical products, since its establishment, Taienkang has been adhering to the corporate philosophy of "Honesty, Enterprise, Sincerity", insisting on being market-oriented, and committed to selecting domestic and foreign characteristics. Carry out in-depth promotion and marketing of competitive pharmaceutical products, provide one-stop services from market demand analysis, marketing strategy planning to product sales, channel expansion to terminal management, customer relationship maintenance, etc., becoming a company with marketing network as its core advantage and focusing on marketization, a relatively high degree of professional marketing of pharmaceutical products. The company grasps the development trend of the industry, prevents operating risks, continuously enhances its ability to control the market, and steadily improves its scale and benefits. At present, Taienkang has formed a marketing network covering 28 provincial-level regions across the country, more than 3,000 hospitals, thousands of distributors and nearly 20,000 terminal pharmacies. Relying on a strong marketing network, rich industry experience, good industry reputation and long-term accumulation of pharmaceutical product marketing and promotion capabilities, the company has successfully marketed the "Fishing Pill IV" of Thailand Liwanshan Medicine Factory (Diaoyu Trademark) Co., Ltd. , Hong Kong Po Sum On Pharmaceutical Co., Ltd.’s "Peppermint Skin Care Oil (Po Sum On Oil)", Lecithin Complex Iodine Tablets (Jolethin) from Japan’s Daiichi Pharmaceutical Industry Co., Ltd. "Xin Snow" brand levonorgestrel dripping pills, medical devices of “Johnson & Johnson” in the United States, and at the same time marketing the self-produced "Wuhuan brand" special external medicine series and "Taienkang" brand sanitary materials and diagnostic reagents and other medical devices. In the highly competitive economic environment of the pharmaceutical industry, we have actively explored the innovation of marketing business models and financing models, and achieved rapid development.

The successful listing on the NEEQ “National Equities Exchange and Quotations” this time is the result of Taienkang’s active innovation in the enterprise development model in recent years, and the exploration and use of the capital market to accelerate the development of the enterprise, and it has also opened a new page in the development process of Taienkang. Chairman Mr. Zheng Hanjie emphasized that the listing on the New Third Board is a milestone for Taienkang, and it marks that Taienkang has entered a new stage of development. Taienkang will take this listing as a new starting point and new impetus, make full use of the capital market to accelerate the pace of enterprise development, expand marketing network, increase production capacity, improve product technology level, optimize product structure, and enhance technology through mergers and acquisitions of domestic high-quality pharmaceutical companies. R & D capabilities, speed up the improvement of Taienkang’s important layout in the integration of research, production and sales in the pharmaceutical industry, further enhance the company’s core competitiveness, increase the company’s market share, achieve rapid growth in performance, and maximize the relationship with customers, employees, A win-win situation for society and shareholders!